The MIXiii Health-Tech.IL, The renowned Israeli biomed industry conference, kicked off in Jerusalem with great success. Hosted by the IATI Association, the conference gathered 1,700 guests and representatives from 32 countries, creating a vibrant platform for innovation in the life sciences and medical technologies industries.
The Association of Advanced Industries IATI officially inaugurated the international conference. The event has drawn attention from across the globe, attracting investors, industry experts, and approximately 1,700 participants eager to explore the latest developments in Israeli startups and cutting-edge medical technologies.
The MIXiii Health-Tech.IL conference serves as a showcase for Israeli ingenuity, highlighting medical technologies in various stages of development. Attendees have the unique opportunity to witness firsthand the impact of these innovations, which are already making a difference in the lives of millions worldwide.
The Association of Advanced Industries IATI officially inaugurated the international conference. The event has drawn attention from across the globe, attracting investors, industry experts, and approximately 1,700 participants eager to explore the latest developments in Israeli startups and cutting-edge medical technologies.
According to Karin Mayer Rubinstein, IATI CEO & President of the Association of Advanced Industries IATI, "The past year has been extremely challenging for the high-tech industry as a whole, and specifically for Israeli life sciences and digital technologies companies operating in Israel and abroad. The reasons for that are well known, as well as the consequences on the Israeli economy and society. I believe that this great challenge can bring creative solutions and create growth, as well as strengthening the confidence of investors in Israeli developments. This will only come with significant actions and close work with the Ministry of Finance and the Israeli Innovation Authority in order to ensure the continuity and business certainty of the life sciences industry".
Photo:L to R : Yaakov Michlin, Ran Blitzer, Dror Bin, Karin Meir Rubinstein
Photo credit Silvia G Golan
